<DOC>
	<DOC>NCT02097316</DOC>
	<brief_summary>The study will be conducted, in cross-over with a time interval of at least 2 days between 2 treatment periods. Patients will be randomized into 2 groups According to the order of the randomization, patients will bear the JewelPump for 5 days, followed by a period of 5 days of treatment with their usual pumps.</brief_summary>
	<brief_title>Feasibility Study of the JewelPump Version 3</brief_title>
	<detailed_description>The JewelPump (Debiotech) will be compared to the conventional pumps. Patients will treated with the JewelPump during 5 days, and with their usual pump during 5 other days. The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Strasbourg, and CHRU of Marseille.</detailed_description>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients type 1 diabetics treated by external insulin pump; Patients with HbA1c &lt; 8.5% Patients who signed consent Patients type 2 diabetics Patients who have all serious diseases that could interfere with the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Glycemic control</keyword>
	<keyword>JewelPump accuracy</keyword>
</DOC>